Antiviral RNAi: Translating Science Towards Therapeutic Success
Identifieur interne : 000C90 ( Main/Exploration ); précédent : 000C89; suivant : 000C91Antiviral RNAi: Translating Science Towards Therapeutic Success
Auteurs : Priya S. Shah [États-Unis] ; David V. Schaffer [États-Unis]Source :
- Pharmaceutical Research [ 0724-8741 ] ; 2011-12-01.
English descriptors
- KwdEn :
Abstract
ABSTRACT: Viruses continuously evolve to contend with an ever-changing environment that involves transmission between hosts and sometimes species, immune responses, and in some cases therapeutic interventions. Given the high mutation rate of viruses relative to the timescales of host evolution and drug development, novel drug classes that are readily screened and translated to the clinic are needed. RNA interference (RNAi)—a natural mechanism for specific degradation of target RNAs that is conserved from plants to invertebrates and vertebrates—can potentially be harnessed to yield therapies with extensive specificity, ease of design, and broad application. In this review, we discuss basic mechanisms of action and therapeutic applications of RNAi, including design considerations and areas for future development in the field.
Url:
DOI: 10.1007/s11095-011-0549-8
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000848
- to stream Istex, to step Curation: 000828
- to stream Istex, to step Checkpoint: 000097
- to stream Main, to step Merge: 000C92
- to stream Main, to step Curation: 000C90
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antiviral RNAi: Translating Science Towards Therapeutic Success</title><author><name sortKey="Shah, Priya S" sort="Shah, Priya S" uniqKey="Shah P" first="Priya S." last="Shah">Priya S. Shah</name></author><author><name sortKey="Schaffer, David V" sort="Schaffer, David V" uniqKey="Schaffer D" first="David V." last="Schaffer">David V. Schaffer</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D63B45FEC0E341566F631466A2B2D648A8FBF71A</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1007/s11095-011-0549-8</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-X8GRXVMF-3/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000848</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000848</idno><idno type="wicri:Area/Istex/Curation">000828</idno><idno type="wicri:Area/Istex/Checkpoint">000097</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000097</idno><idno type="wicri:doubleKey">0724-8741:2011:Shah P:antiviral:rnai:translating</idno><idno type="wicri:Area/Main/Merge">000C92</idno><idno type="wicri:Area/Main/Curation">000C90</idno><idno type="wicri:Area/Main/Exploration">000C90</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Antiviral RNAi: Translating Science Towards Therapeutic Success</title><author><name sortKey="Shah, Priya S" sort="Shah, Priya S" uniqKey="Shah P" first="Priya S." last="Shah">Priya S. Shah</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Chemical and Biolmolecular Engineering, University of California, 94720, Berkeley, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Schaffer, David V" sort="Schaffer, David V" uniqKey="Schaffer D" first="David V." last="Schaffer">David V. Schaffer</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Chemical and Biolmolecular Engineering, University of California, 94720, Berkeley, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Bioengineering, University of California, 94720, Berkeley, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Helen Wills Neuroscience Institute, University of California, 94720, Berkeley, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Pharmaceutical Research</title><title level="j" type="sub">An Official Journal of the American Association of Pharmaceutical Scientists</title><title level="j" type="abbrev">Pharm Res</title><idno type="ISSN">0724-8741</idno><idno type="eISSN">1573-904X</idno><imprint><publisher>Springer US; http://www.springer-ny.com</publisher><pubPlace>Boston</pubPlace><date type="published" when="2011-12-01">2011-12-01</date><biblScope unit="volume">28</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="2966">2966</biblScope><biblScope unit="page" to="2982">2982</biblScope></imprint><idno type="ISSN">0724-8741</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0724-8741</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>RNA interference (RNAi)</term><term>antiviral</term><term>gene therapy</term><term>viral escape</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">ABSTRACT: Viruses continuously evolve to contend with an ever-changing environment that involves transmission between hosts and sometimes species, immune responses, and in some cases therapeutic interventions. Given the high mutation rate of viruses relative to the timescales of host evolution and drug development, novel drug classes that are readily screened and translated to the clinic are needed. RNA interference (RNAi)—a natural mechanism for specific degradation of target RNAs that is conserved from plants to invertebrates and vertebrates—can potentially be harnessed to yield therapies with extensive specificity, ease of design, and broad application. In this review, we discuss basic mechanisms of action and therapeutic applications of RNAi, including design considerations and areas for future development in the field.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li></region></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Shah, Priya S" sort="Shah, Priya S" uniqKey="Shah P" first="Priya S." last="Shah">Priya S. Shah</name></region><name sortKey="Schaffer, David V" sort="Schaffer, David V" uniqKey="Schaffer D" first="David V." last="Schaffer">David V. Schaffer</name><name sortKey="Schaffer, David V" sort="Schaffer, David V" uniqKey="Schaffer D" first="David V." last="Schaffer">David V. Schaffer</name><name sortKey="Schaffer, David V" sort="Schaffer, David V" uniqKey="Schaffer D" first="David V." last="Schaffer">David V. Schaffer</name><name sortKey="Schaffer, David V" sort="Schaffer, David V" uniqKey="Schaffer D" first="David V." last="Schaffer">David V. Schaffer</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C90 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C90 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D63B45FEC0E341566F631466A2B2D648A8FBF71A
|texte= Antiviral RNAi: Translating Science Towards Therapeutic Success
}}
| This area was generated with Dilib version V0.6.33. |  |